Publication | Open Access

Effects of combination PPARγ agonist and angiotensin receptor blocker on glomerulosclerosis

Glomerular DiseaseMolecular PharmacologyGlomerulonephritisHypertensionCombination Pparγ AgonistMedicineAntihypertensive TherapyPhysiologyRenal InflammationVascular BiologyRenal PathophysiologyAngiotensin Receptor BlockerPharmacologyRenal PharmacologyNephrologyKidney Research